GBLXGB Sciences, Inc.

About GB Sciences, Inc. (GBLX)

GB Sciences, Inc. (GBLX) is a Biotechnology company headquartered in Las Vegas, NV, United States whose shares trade over-the-counter on the Expert Market tier.

GB Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market.

Products and services

Patented formulations of plant-inspired, complex therapeutic mixtures that target a variety of medical conditions.

GBLX key facts

Ticker symbol

GBLX

Market tier

Expert Market

Sector

Healthcare

Industry

Biotechnology

Headquarters

Las Vegas, NV, United States

Country of incorporation

US

Year of incorporation

2018

Employees

4

Estimated market cap

$80.5K (as of Apr 11, 2025)

Shares outstanding

402,737,695

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

3/31

GB Sciences, Inc. leadership

• John Poss — CEO, Interim CFO
• Andrea Small-Howard — President, Chief Scientific Officer
• Edmond DeFrank — Consultant

Explore more: Biotechnology stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with G